Showing results (5411-5420 of 5,703) with videos related to
Sort By:
Pageof 571
The Oncologist|April 19, 2002
The effect of nonmalignant systemic disease on tolerance to radiation therapyBrian H Chon, Jay S LoefflerThe Oncologist|May 17, 2017
Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic OptionsJessica M Moskovitz, Jennifer Moy, Tanguy Y Seiwert, et al.The Oncologist|May 17, 2017
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line GefitinibZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.The Oncologist|May 21, 2017
Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II StudiesMitsuru Takahashi, Shunji Takahashi, Nobuhito Araki, et al.The Oncologist|May 24, 2017
FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing ChemotherapyErin Larkins, Gideon M Blumenthal, Weishi Yuan, et al.The Oncologist|May 24, 2017
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate DataPetr Szturz, Kristien Wouters, Naomi Kiyota, et al.The Oncologist|July 1, 2018
Developing a Roadmap for Interventional OncologyStefan O Schoenberg, Ulrike I Attenberger, Stephen B Solomon, et al.The Oncologist|July 1, 2018
Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled TrialInge Henselmans, Hanneke W M van Laarhoven, Hanneke C J M de Haes, et al.The Oncologist|July 19, 2018
FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic LeukemiaE Dianne Pulte, Jonathon Vallejo, Donna Przepiorka, et al.Pageof 571